Dr. Frederick Brown

11/07/2023

“The life so short, the craft so long to learn.”

11/05/2023

11/02/2023

Enhancing success rate in transcatheter closure of paravalvular leaks post-TAVI with vascular plug technology.

This commentary refers to ‘Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications’, by U. Landes et

10/31/2023

Scientific presentations serve as a platform for researchers to share their work and engage with their peers. Science and academia rely heavily on effective communication to share knowledge and foster collaboration. Science and academia are domains deeply rooted in the pursuit of knowledge and the exchange of ideas. While the focus is often on the content of research papers, lectures, and presentations, there is another form of communication that plays a significant role in these fields: body language. Non-verbal cues, such as facial expressions, gestures, posture, and eye contact, can convey a wealth of information, often subtly influencing interpersonal dynamics and the perception of scientific work. In this article, we will delve into the unspoken science of body language, exploring its significance in science and academia. It is essential to emphasize on the importance of body language in scientific and academic settings, highlighting its impact on presentations, interactions, interviews, and collaborations. Additionally, cultural considerations and the implications for cross-cultural communication are explored. By understanding the unspoken science of body language, researchers and academics can enhance their communication skills and promote a more inclusive and productive scientific community.

Scientific presentations serve as a platform for researchers to share their work and engage with their peers. Science and academia rely heavily on effective com

10/30/2023

Physician Health Services is dedicated to improving the health, well-being, and effectiveness of and . Don't wait to get the confidential help you need. Learn more: https://ow.ly/Mx1N50PF9CN

10/30/2023

In 2019, at age 24, Alexis Browning was diagnosed with stage IV alveolar soft part sarcoma, a rare cancer with a very low survival rate. She enrolled in a clinical trial for an immune checkpoint inhibitor, atezolizumab, which received FDA approval in 2022. Her disease has remained stable, and she continues to receive the treatment. Learn more in the AACR Cancer Progress Report:
https://bit.ly/3saBMu2

10/30/2023

Advanced life support training is declining for medical students and junior doctors; this risks leaving them unprepared for medical emergencies, write Umika Moorjani , James Patrick , and Kwaku Baryeh In 2021, Health Education England removed advanced life support as a mandatory component of foundat...